Acura Pharmaceuticals
Palatine
About Acura Pharmaceuticals
Acura Pharmaceuticals, is a specialty pharmaceutical company developing and commercializing tamper-resistant products to combat medication abuse and misuse. The Centers for Disease Control and Prevention estimates that one person dies every 19 minutes from prescription drug abuse in the United States. For nearly a decade, Acura has been at the forefront of developing solutions to combat this epidemic, with products utilizing the Company’s proprietary abuse-deterrent AVERSION® and IMPEDE® Technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.3M
- Funding stage: IPO
- Last round: Grant (Aug 2014)
- Ticker: otcqb:ACUR
- Website: acurapharm.com
- Phone: +1 (574)842-2519
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/acura-pharmaceuticals-3407741 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.